Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In cortisone reductase deficiency (CRD), activation of cortisone to cortisol does not occur, resulting in adrenocorticotropin-mediated androgen excess and a phenotype resembling polycystic ovary syndrome (PCOS; refs. 1,2). This suggests a defect in the gene HSD11B1 encoding 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), a primary regulator of tissue-specific glucocorticoid bioavailability. We identified intronic mutations in HSD11B1 that resulted in reduced gene transcription in three individuals with CRD. In vivo, 11beta-HSD1 catalyzes the reduction of cortisone to cortisol whereas purified enzyme acts as a dehydrogenase converting cortisol to cortisone. Oxo-reductase activity can be regained using a NADPH-regeneration system and the cytosolic enzyme glucose-6-phosphate dehydrogenase. But the catalytic domain of 11beta-HSD1 faces into the lumen of the endoplasmic reticulum (ER; ref. 6). We hypothesized that endolumenal hexose-6-phosphate dehydrogenase (H6PDH) regenerates NADPH in the ER, thereby influencing directionality of 11beta-HSD1 activity. Mutations in exon 5 of H6PD in individuals with CRD attenuated or abolished H6PDH activity. These individuals have mutations in both HSD11B1 and H6PD in a triallelic digenic model of inheritance, resulting in low 11beta-HSD1 expression and ER NADPH generation with loss of 11beta-HSD1 oxo-reductase activity. CRD defines a new ER-specific redox potential and establishes H6PDH as a potential factor in the pathogenesis of PCO…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This disorder is caused by inactivating mutations in H6PDH (590), which impair NADPH regeneration within the endoplasmic reticulum, rather than by mutations in the coding regions of HSD11B1.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [590]
In the citing paper
“Elevated anti-Müllerian hormone (AMH) levels have been a consistent hormonal finding associated with PCOM in healthy girls [90,91]”
From The Diagnosis of Polycystic Ovary Syndrome during Adolescence (2015) · cites this paper as [91]
In the citing paper
“Cortisone reductase deficiency (CRD) and apparent CRD (ACRD) are characterised by the failure to generate cortisol from inactive cortisone resulting in HPA axis activation and excessive ACTH-mediated adrenal androgen secretion, with ∼14 cases described clinically and biochemically in the literature (1, 2, 3, 4, 5, 6, 7, 8, 9) .”
From Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling (2013) · cites this paper as [2]
In the citing paper
“CRD is caused by HSD11B1 deficiency (90) whereas ACRD results form a deficiency in the activity of H6PDH, which is essential for maintaining the reductive activity of HSD11B1 in vivo by the reduced form of NAD phosphate provision to the enzyme (91, 92).”
From Steroid Metabolome Analysis in Disorders of Adrenal Steroid Biosynthesis and Metabolism (2019) · cites this paper as [91]
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“) and adipose tissue (increased adipocyte differentiation and visceral obesit”
BackgroundCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Self-citationGlucose-6-phosphate Dehydrogenase
Löhr, G. W., & Waller, H. D. (1974) · Methods of Enzymatic Analysis · doi:10.1016/b978-0-12-091302-2.50026-8 · Cited by 1,190
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Digenic Retinitis Pigmentosa Due to Mutations at the Unlinked Peripherin/ RDS and ROM1 Loci
Kajiwara, K., Berson, E. L., & Dryja, T. P. (1994) · Science · doi:10.1126/science.8202715 · Cited by 775
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Self-citation11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationTriallelic Inheritance in Bardet-Biedl Syndrome, a Mendelian Recessive Disorder
Katsanis, N., Ansley, S. J., Badano, J. L., Eichers, E. R., Lewis, R. A., Hoskins, B. E., Scambler, P. J., Davidson, W. S., Beales, P. L., & Lupski, J. R. (2001) · Science · doi:10.1126/science.1063525 · Cited by 655 · cited 1×
“To our knowledge, however, there are only a few documented examples of a digenic triallelic trait: Bardet–Biedl syndrome, a heterogeneous disorder with symptoms including mental retardation, pigmentary retinopathy and obesit”
BackgroundKletzien, R. F., Harris, P. K. W., & Foellmi, L. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119488 · Cited by 550
Cited by
Items 101–200 of 288
The pituitary–adrenal axis and body composition
Fernandez-Rodriguez, E., Stewart, P. M., & Cooper, M. S. (2009) · Pituitary · doi:10.1007/s11102-008-0098-2 · Cited by 49
“This capacity to switch from an inactiving to an activating enzyme appears due to variable expression of a cofactor generating enzyme that is needed for glucocorticoid generation [27].”
BackgroundSelf-citationGambineri, A., Tomassoni, F., Munarini, A., Stimson, R. H., Mioni, R., Pagotto, U., Chapman, K. E., Andrew, R., Mantovani, V., Pasquali, R., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0091 · Cited by 55
Venkatesh, S. S., Wittemans, L. B. L., Palmer, D. S., Baya, N. A., Ferreira, T. C., Hill, B., Lassen, F. H., Parker, M. J., Reibe, S., Elhakeem, A., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02156-8 · Cited by 56
“…HSD11B1 with testosterone-F (burden test P = 1.93 × 10 −6 when aggregated across missense variants with MAF <0.01%), with nominal replication in deCODE ( P = 0.028); pathogenic variants in this gene are reported to cause hyperandrogenism due to cortisone reductase deficiency 49 (Supplementary Fig.”
InfluentialGenomic variants in polycystic ovary syndrome
Luque‐Ramírez, M., Millán, J. L. S., & Escobar-Morreale, H. F. (2005) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.017 · Cited by 54
Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism
White, P. C., Rogoff, D., McMillan, D. R., & Lavery, G. G. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.022 · Cited by 50
“The combined genotype of H6PD R453Q homozygosity and HSD11B1 intron 3 G heterozygosity was predicted to occur in approximately 0.8% of the population, which did not seem inconsistent with the apparent rarity of ACRD if the disease was poorly ascertained (Draper et al., 2003).”
BackgroundResultInfluentialSelf-citationWhite, P. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0942 · Cited by 47
Self-citationDensmore, V. S., Morton, N. M., Mullins, J. J., & Seckl, J. R. (2006) · Endocrinology · doi:10.1210/en.2006-0106 · Cited by 47
“Second, arcuate 11 -HSD1 might act as a dehydrogenase, inactivating corticosterone, as proposed to occur in human preadipocytes lacking enzyme cofactor (NADPH) generation systems (52, 53).”
Armanini, D., Bordin, L., Donà, G., Sabbadin, C., Bakdounes, L., Ragazzi, E., Giorgino, F. L., & Fiore, C. (2012) · Steroids · doi:10.1016/j.steroids.2012.02.010 · Cited by 45
“[11] described a correlation between androgen levels and blood pressure, irrespective of age, insulin resistance, obesity, or dyslipidemia, in PCOS patients: these results led us to hypothesize that high androgen and aldosterone levels could also be related to a subtle increase in ACTH due to reduced type 1 11-beta-hy…”
ResultAdrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Actions of glucocorticoid and their regulatory mechanisms in the ovary
TETSUKA, M. (2007) · Animal Science Journal · doi:10.1111/j.1740-0929.2007.00414.x · Cited by 46
Cortisol Biosynthesis in the Human Ocular Surface Innate Immune Response
Susarla, R., Liu, L., Walker, E. A., Bujalska, I. J., Al-Salem, J. A., Williams, G. P., Sreekantam, S., TAYLOR, A. E. R., Tallouzi, M., Southworth, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094913 · Cited by 43
Self-citationThieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 48
11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases
Kupczyk, D., Bilski, R., Kozakiewicz, M., Studzińska, R., Kędziora–Kornatowska, K., Kosmalski, T., Pedrycz, A., & Głowacka, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168984 · Cited by 48
Bujalska, I. J., Durrani, O. M., Abbott, J. A., Onyimba, C., Khosla, P., Moosavi, A., Reuser, T. T. Q., Stewart, P. M., Tomlinson, J., Walker, E. A., et al. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0042 · Cited by 47
“…in vivo it functions as an oxo-reductase activating cortisol from cortisone due to the provision of a cofactor, NADPH, by a second regulatory enzyme, hexose6-phosphate dehydrogenase (H6PDH), thereby mediating glucocorticoid receptor (GR) responses (Draper et al. 2003, Bujalska et al. 2005).”
BackgroundSelf-citationOdermatt, A., & Nashev, L. G. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.007 · Cited by 51
Nashev, L. G., Chandsawangbhuwana, C., Balazs, Z., Atanasov, A. G., Dick, B., Frey, F. J., Baker, M. E., & Odermatt, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000561 · Cited by 42
“hexose-6-phosphate dehydrogenase (H6PDH) generates NADPH in the endoplasmic reticulum (ER) lumen, which causes 11β-HSD1 to function as a reductase”
BackgroundZemanová, L., & Wsól, V. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.638304 · Cited by 43
“Some of the symptoms of women affected with CRD are polycystic ovary syndrome, hirsutism, and infertility resulting from the very low concentration of cortisol (Draper et al., 2003).”
BackgroundTu, H., Powers, J. P., Liu, J., Ursu, S., Sudom, A. M., Yan, X., Xu, H., Meininger, D. P., DeGraffenreid, M. R., He, X., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.065 · Cited by 46
Isocitrate dehydrogenase: A NADPH-generating enzyme in the lumen of the endoplasmic reticulum
Margittai, É., & Bánhegyi, G. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.12.017 · Cited by 41
Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Paterson, J. M., Seckl, J. R., & Mullins, J. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00017.2005 · Cited by 50
“The potential importance of cofactor availability has been highlighted in a recent report of corticosteroid reductase deficiency in humans precipitated by compound heterozygous mutations in both the 11 -HSD1 gene and the hexose-6phosphate dehydrogenase gene, encoding a major enzyme for synthesis of NADP(H) in the ER l…”
BackgroundLack of Hexose-6-Phosphate Dehydrogenase Impairs Lipid Mobilization from Mouse Adipose Tissue
Bujalska, I. J., Hewitt, K., Hauton, D., Lavery, G. G., Tomlinson, J., Walker, E. A., & Stewart, P. M. (2008) · Endocrinology · doi:10.1210/en.2007-1705 · Cited by 44
Self-citationAnalysis of the EFEMP1 gene in individuals and families with early onset drusen
Narendran, N., Guymer, R. H., Cain, M. S., & Baird, P. N. (2004) · Eye · doi:10.1038/sj.eye.6701435 · Cited by 38
Zhang, Y., Zhong, X., Gjoka, Z., Li, Y., Stochaj, W. R., Stahl, M., Kriz, R., Tobin, J. F., Erbe, D. V., & Suri, V. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.004 · Cited by 44
Mitić, T., Shave, S., Semjonous, N. M., McNae, I. W., Cobice, D., Lavery, G. G., Webster, S. P., Hadoke, P. W. F., Walker, B. R., & Andrew, R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.002 · Cited by 39
Self-citationAlterations of Cortisol Metabolism in Human Disorders
White, P. C. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485508 · Cited by 39
Self-citation11β‐Hydroxysteroid Dehydrogenase Type 1 in Obesity
Walker, B. R. (2004) · Obesity Research · doi:10.1038/oby.2004.1 · Cited by 36
Chan, J., Rabbitt, E. H., Innes, B. A., Bulmer, J. N., Stewart, P. M., Kilby, M. D., & Hewison, M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0289 · Cited by 34
“Previous studies have shown that expression of Fas ligand was decreased in uNK cells from women with preeclampsia, possibly reflecting a reduced ability of these cells to undergo Fas‐Fas ligand-mediated apoptosis ( Darmochwal-Kolarz et al. 2000 ).”
ResultSelf-citationMitrašinović‐Brulić, M., Buljan, M., & Suljević, D. (2021) · Middle East Fertility Society Journal · doi:10.1186/s43043-021-00085-0 · Cited by 41
“11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD type 1) deficiency disables the conversion of cortisone to cortisol, increasing adrenocorticotropic hormone (ACTH) which stimulates androgen production and leads to expression of the PCOS phenotype [19].”
BackgroundChua, A. K., Azziz, R., & Goodarzi, M. O. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas002 · Cited by 32
Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 37
Relative adrenal insufficiency in mice deficient in 5α-reductase 1
Livingstone, D. E. W., Rollo, E. M. D., Yang, C., Lucy, C., Mathews, J. A., Kara, M., Hughes, K. A., Kenyon, C. J., Walker, B. R., & Andrew, R. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0563 · Cited by 37
“…scenario, where enhanced cortisol clearance in patients with rare Hsd11b1 or hexose6-phosphate dehydrogenase deficiency results in increased ACTH drive to the adrenals, and hence elevated adrenal androgens (Taylor et al. 1984, Phillipov et al. 1996, Jamieson et al. 1999, Draper et al. 2003).”
BackgroundLöffler, M. G., Bilban, M., Reimers, M., Waldhäusl, W. K., & Stulnig, T. M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093831 · Cited by 37
“Since oxo-reductase activity of Hsd11b1 depends on NADPH, mutations in hexose-6-phosphate dehydrogenase (H6pd) synergize with weak Hsd11b1 mutations in glucocorticoid activation (Draper et al., 2003).”
BackgroundDiagnosis of Diseases of Steroid Hormone Production, Metabolism and Action
Honour, J. W. (2009) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v1i5.209 · Cited by 32
Molecular Screening of the 11β‐HSD1 Gene in Men Characterized by the Metabolic Syndrome
Robitaille, J., Brouillette, C., Houde, A., Després, J., Tchernof, A., & Vohl, M. (2004) · Obesity Research · doi:10.1038/oby.2004.196 · Cited by 35
“Both variants identified in intron 3 have been previously described in individuals with cortisone reductase deficiency (9).”
BackgroundZhu, L., Hou, M., Sun, B., Burén, J., Zhang, L., Yi, J., Hernell, O., & Li, X. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2708 · Cited by 32
Time of the day for 11β‐HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice
Véniant, M. M., Hale, C., Komorowski, R., Chen, M. M., Jean, D. J. S., Fotsch, C. H., & Wang, M. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00911.x · Cited by 32
Wang, Y., Nakagawa, Y., Liu, L., Wang, W., Ren, X., Anghel, A., Lutfy, K., Friedman, T. C., & Liu, Y. (2010) · Diabetologia · doi:10.1007/s00125-010-1956-9 · Cited by 29
“Our results are consistent with those of earlier reports that cortisone increased H6PDH activity leading to 11ß-HSD1 amplifying cortisol production in rat liver microsomal fractions [34].”
London, E., Lala, G., Berger, R., Panzenbeck, A., Kohli, A., Renner, M., Jackson, A., Raynor, T., Loya, K., & Castonguay, T. W. (2007) · Journal of Nutrition · doi:10.1093/jn/137.12.2616 · Cited by 36
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Czegle, I., Csala, M., Mandl, J., Benedetti, A., Karádi, I., & Bánhegyi, G. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.129 · Cited by 30
Draper, N., Powell, B. L., Franks, S., Conway, G. S., Stewart, P. M., & McCarthy, M. I. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02547.x · Cited by 27
Self-citationTETSUKA, M., Nishimoto, H., Miyamoto, A., Okuda, K., & Hamano, S. (2010) · Journal of Reproduction and Development · doi:10.1262/jrd.10-019k · Cited by 27
Smit, P., Dekker, M. J. H. J., de Jong, F. J., van den Beld, A. W., Koper, J. W., Pols, H. A. P., Brinkmann, A. O., de Jong, F. H., Breteler, M. M. B., & Lamberts, S. W. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1349 · Cited by 26
High-resolution structural-omics of human liver enzymes
Su, C., Lyu, M., Zhang, Z., Miyagi, M., Huang, W., Taylor, D. J., & Yu, E. W. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112609 · Cited by 26
“10,11 Despite its importance in the pentose phosphate pathway, 10,11 to date there has been no structural information obtained from this liver enzyme.”
The Role of 11ß-Hydroxysteroid Dehydrogenase 1 in Adipogenesis in Thyroid-Associated Ophthalmopathy
Tomlinson, J., Durrani, O. M., Bujalska, I. J., Gathercole, L., Tomlins, P. J., Reuser, T. T. Q., Rose, G. E., Curnow, J., Stewart, P. M., Walker, E. A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0873 · Cited by 29
Self-citationInvolvement of GR and p300 in the Induction of H6PD by Cortisol in Human Amnion Fibroblasts
Wang, W., Guo, C., Li, W., Li, J., Wang, W., Myatt, L., & Sun, K. (2012) · Endocrinology · doi:10.1210/en.2012-1531 · Cited by 25
Hexose monophosphate shunt, the role of its metabolites and associated disorders: A review
Akram, M., Shah, S. M. A., Munir, N., Daniyal, M., Tahir, I. M., Mahmood, Z., Irshad, M., Akhlaq, M., Sultana, S., & Zainab, R. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28228 · Cited by 25
Chandras, C., Harris, T. E., Bernal, A. L., Abayasekara, D. R. E., & Michael, A. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0128 · Cited by 27
“…form of nicotinamide adenine dinucleotide phosphate to its oxidised form (NADPH: NADPC) within the lumen of the smooth endoplasmic reticulum (Draper et al. 2003, Atanasov et al. 2004, Banhegyi et al. 2004, Bujalska et al. 2005, McCormick et al. 2006) such that changes in this ratio in…”
BackgroundBiason‐Lauber, A., Boscaro, M., Mantero, F., & Balercia, G. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346683 · Cited by 25
Malavasi, E. L. V., Kelly, V., Nath, N., Gambineri, A., Dakin, R. S., Pagotto, U., Pasquali, R., Walker, B. R., & Chapman, K. E. (2009) · Endocrinology · doi:10.1210/en.2009-0663 · Cited by 28
“Indeed, in our recent study, the combination of less common alleles at both rs846910 and at rs12086634, a polymorphism previously shown to influence transcription (19), was associated with more prevalent Metabolic Syndrome and higher adipose 11β-HSD1 activity (Gambineri, A.”
Thurston, L. M., Abayasekara, D. R. E., & Michael, A. E. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07025 · Cited by 29
“…glucose-6-phosphate to 6-phosphogluconate by H6PDH maintains a high concentration of NADPH in the lumen of the smooth endoplasmic reticulum, which favours the 11KSR activity of 11 b HSD1 (Draper et al. 2003, Atanasov et al. 2004, Banhegyi et al. 2004, Bujalska et al. 2005, McCormick et al. 2006).”
BackgroundÜçkaya, G., Karadurmuş, N., Kutlu, O. C., Çorakçı, A., Kızıldağ, S., Ural, A. U., Gül, D., & Kutlu, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.022 · Cited by 24
“Patients with cortisone oxo-reductase deficiency have mutations in both HSD11B1 and H6PD genes, causing decreased expression of HSD11B1 and H6PD, and resulting in reduced H6PD activity [9].”
BackgroundAhmed, A., Saksena, S., Sherlock, M., Olliff, S. P., Elias, E., & Stewart, P. M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03125.x · Cited by 24
Self-citationBrondani, L. D. A., Duarte, G. C. K., Canani, L. H. S., & Crispim, D. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0077 · Cited by 23
“34,35 This is a useful method to analyze the combination between two polymorphisms when one of them is rare (in our case, the ADRB3 Trp64Arg polymorphism) once it dichotomizes the sample to only two groups of polymorphic combinations, increasing the statistical power.”
Sunak, N., Green, D. F., Abeydeera, L. R., Thurston, L. M., & Michael, A. E. (2007) · Reproduction · doi:10.1530/rep-07-0003 · Cited by 30
“…regeneration of NADPH in the lumen of the smooth endoplasmic reticulum by hexose-6-phosphate dehydrogenase drives the reductase activity of 11bHSD1 (Low et al. 1994, Jamieson et al. 1995, Seckl & Walker 2001, Draper et al. 2003, Atanasov et al. 2004, Banhegyi et al. 2004, McCormick et al. 2006).”
BackgroundFeldman, K., Szappanos, Á., Butz, H., Grolmusz, V. K., Majnik, J., Likó, I., Kriszt, B., Lakatos, P. L., Tóth, M., Rácz, K., et al. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.014 · Cited by 25
“Previous functional studies also showed that some genetic variants have reduced transcriptional activity [11,12].”
Legeza, B., Balázs, Z., Nashev, L. G., & Odermatt, A. (2012) · Endocrinology · doi:10.1210/en.2012-1778 · Cited by 26
Valkenburg, O., Uitterlinden, A. G., Themmen, A. P. N., de Jong, F. H., Albert Hofman, D., Fauser, B. C. J. M., & Laven, J. S. E. (2011) · Human Reproduction · doi:10.1093/humrep/der222 · Cited by 26
“Downloaded from https://academic.oup.com/humrep/article-abstract/26/10/2902/608423 by guest on 26 July 2018 Two genetic variants of HSD11B1 (83557 ins-A) and H6PD (rs6688832) have been implicated in the pathophysiology of cortisone reductase deficiency (Draper et al., 2003).”
BackgroundMethodInfluentialGenetic Disorders of Steroid Metabolism Diagnosed by Mass Spectrometry
Shackleton, C. H. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-76698-8_26 · Cited by 26
Self-citationNg, B., Sosicka, P., Fenaille, F., Harroche, A., Vuillaumier‐Barrot, S., Porterfield, M., Xia, Z., Wagner, S. M., Bamshad, M. J., Vergnes-Boiteux, M.-C., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.04.013 · Cited by 23
Tagawa, N., Minamitani, E., Yamaguchi, Y., & Kobayashi, Y. (2011) · Steroids · doi:10.1016/j.steroids.2011.09.005 · Cited by 26
“Since 11b-HSD1 is colocalized in the intralumen of the endoplasmic reticulum membrane with hexose-6-phosphate dehydrogenase (H6PD), which supplies NADPH to 11b-HSD1 [37,38], H6PD would drive the reductase activity of 11b-HSD1.”
Michael, A. E., Glenn, C., Wood, P. J., Webb, R. J., Pellatt, L., & Mason, H. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1385 · Cited by 24
Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE‐knockout mice
Zurkinden, L., Solcà, C., Vögeli, I., Vogt, B., Ackermann, D., Erickson, S. K., Frey, F. J., Sviridov, D., & Escher, G. (2013) · The FASEB Journal · doi:10.1096/fj.13-233791 · Cited by 21
Miyamoto, Y., Morisaki, H., Yamanaka, I., Kokubo, Y., Masuzaki, H., Okayama, A., Tomoike, H., Nakao, K., Okamura, T., Yoshimasa, Y., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.05.017 · Cited by 23
Why do humans have two glucocorticoids: A question of intestinal fortitude
Morris, D. J. (2015) · Steroids · doi:10.1016/j.steroids.2015.06.017 · Cited by 22
Tsartsali, L., Papadopoulos, M., Lagona, E., Papadimitriou, A., Kanaka‐Gantenbein, C., Louizou, E., Kastania, A., Priftis, K. Ν., & Chrousos, G. P. (2012) · NeuroImmunoModulation · doi:10.1159/000329592 · Cited by 22
Arai, H., Kobayashi, N., Nakatsuru, Y., Masuzaki, H., Nambu, T., Takaya, K., YAMANAKA, Y., Kondo, E., Yamada, G., Fujii, T., et al. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-008 · Cited by 21
The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1
Zhou, H.-Y., Hu, G., Lian, Q., Morris, D. J., & Ge, R. (2011) · Toxicology · doi:10.1016/j.tox.2011.11.012 · Cited by 22
Cortisol and the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.42 · Cited by 23
Biochemistry and physiology of hexose-6-phosphate knockout mice
Zielinska, A. E., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.004 · Cited by 20
Self-citationHonour, J. W., Conway, E., Hodkinson, R., & Lam, F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.02.013 · Cited by 20
A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children
Olza, J., Gil‐Campos, M., Leis, R., Rupérez, A. I., Tojo, R., Cañete, R., Gil, Á., & Aguilera, C. M. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.4 · Cited by 22
Tureck, L. V., Leite, N., de Souza, R. L. R., Lima, J. K., Milano, G. E., Timossi, L. D. S., Osiecki, A. C. V., Osiecki, R., & Alle, L. F. (2014) · Genetics and Molecular Biology · doi:10.1590/s1415-47572014000400003 · Cited by 21
“The G allele of SNP rs12086634 was associated with lower transcriptional activity in vitro (Draper et al., 2003), whereas the less frequent allele combination (A and G) for these two SNPs The data are expressed as the mean SEM of the number of individuals indicated in parentheses.”
BackgroundOrefice, N. S., Carotenuto, A., Mangone, G., Bues, B., Rehm, R., Cerillo, I., Saccà, F., Calignano, A., & Orefice, G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.012 · Cited by 19
Woods, C. P., & Tomlinson, J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_16 · Cited by 20
Self-citationCofactor-specific modulation of 11β-hydroxysteroid dehydrogenase 1 inhibitor potency
Sahni-Arya, B., Flynn, M. J., Bergeron, L., Salyan, M. E. K., Pedicord, D. L., Golla, R., Ma, Z., Wang, H., Seethala, R., Wu, S. C., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.07.005 · Cited by 18
Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men
Anderson, A. J., Andrew, R., Homer, N. Z. M., Hughes, K. A., Boyle, L. D., Nixon, M., Karpe, F., Stimson, R. H., & Walker, B. R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa896 · Cited by 19
Sharp, V., Thurston, L. M., Fowkes, R. C., & Michael, A. E. (2007) · Reproduction · doi:10.1530/rep-07-0126 · Cited by 18
Adult Female Acne: Recent Advances in Pathophysiology and Therapeutic Approaches
Amuzescu, A., Tampa, M. Ş., Matei, C., & Georgescu, S. R. (2024) · Cosmetics · doi:10.3390/cosmetics11030074 · Cited by 22
Sharma, M., Vikram, N. K., Misra, A., Bhatt, S., Tarique, M., Parray, H. A., Pandey, R. M., & Luthra, K. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2738-5 · Cited by 22
Glucocorticoid synthesis-related genes:HSD11B1andHSD11B2in hypertensive disorders in pregnancy
Shimodaira, M., Nakayama, T., Sato, I., Sato, N., Izawa, N., Mizutani, Y., Furuya, K., & Yamamoto, T. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.788623 · Cited by 18
Liu, H., Guo, D., Ruzi, A., Chen, Y., Pan, T., Yang, F., Li, J., Xu, K., Zhou, T., Qin, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179353 · Cited by 17
Onyimba, C., Vijapurapu, N., Curnow, J., Khosla, P., Stewart, P. M., Murray, P. I., Walker, E. A., & Rauz, S. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06840 · Cited by 22
“In vivo oxo-reductase activity (cortisone/ cortisol) predominates through the provision of cofactor (NADPH) by hexose-6-phosphate dehydrogenase, thereby mediating classical GC responses (Draper et al. 2003, Bujalska et al. 2005).”
BackgroundSelf-citation2 Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Su, X., Vicker, N., & Potter, B. V. L. (2008) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(07)00002-1 · Cited by 18
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes
Wan, Z., Chenail, E., Li, H., Ipek, M., Xiang, J. S., Suri, V., Hahm, S., Bard, J., Svenson, K., Xu, X., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300352x · Cited by 16
Martínez-García, M. Á., San‐Millán, J. L., & Escobar-Morreale, H. F. (2012) · Gene · doi:10.1016/j.gene.2012.01.047 · Cited by 16
Dujić, T., Bego, T., Mlinar, B., Semiz, S., Malenica, M., Prnjavorac, B., Ostanek, B., Marc, J., & Čaušević, A. (2012) · Biochemia Medica · doi:10.11613/bm.2012.008 · Cited by 16
“HbA1c (mmol/mol) 43 (37-55) 38 (29-42) <0.”
Deary, I. J., Hayward, C., Permana, P. A., Nair, S., Whalley, L. J., Starr, J. M., Chapman, K. E., Walker, B. R., & Seckl, J. R. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.047 · Cited by 16
Agarwal, A. K. (2003) · Endocrine Research · doi:10.1081/erc-120026947 · Cited by 18
“A parallel inheritance of mutations in microsomal H6PDH further reduced the 11b-HSD1 enzyme activity, thus suggesting the role of the intracellular levels of NADPH in determining the directionality of the 11b-HSD1 enzyme (20).”
BackgroundIs ?Cushing?s disease of the omentum? an affliction of mouse and men?
Walker, B. R. (2004) · Diabetologia · doi:10.1007/s00125-004-1390-y · Cited by 16
Physiological roles of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase
White, P. C., Rogoff, D., & McMillan, D. R. (2008) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328305e439 · Cited by 16
Self-citationLatif, S. A., Shen, M., Ge, R., Sottas, C. M., Hardy, M. P., & Morris, D. J. (2011) · Steroids · doi:10.1016/j.steroids.2011.03.007 · Cited by 16
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Senesi, S., Marcolongo, P., Manini, I., Fulceri, R., Sorrentino, V., Csala, M., Bánhegyi, G., & Benedetti, A. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0028 · Cited by 14
“The local activation of glucocorticoids could have various pathophysiological roles, such as stimulation of adipogenesis (Seckl & Walker 2004, Tomlinson et al. 2004, Draper & Stewart 2005 ).”
BackgroundMoreira, R. P. P., Jorge, A. A. L., Gomes, L. G., Kaupert, L. C., Filho, J. M., Mendonca, B. B., & Bachega, T. A. S. S. (2011) · Clinics · doi:10.1590/s1807-59322011000800009 · Cited by 17
Chedid, M. F., do Nascimento, F. V., de Oliveira, F. S., de Souza, B. M., Kruel, C. D. P., Gurski, R. R., Canani, L. H. S., Crispim, D., & Gerchman, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0474-2 · Cited by 14
Webb, R. J., Sunak, N., Wren, L. M., & Michael, A. E. (2008) · Reproduction · doi:10.1530/rep-08-0289 · Cited by 14
“as a dehydrogenase to inactivate cortisol (White et al. 1997, Kotelevtsev et al. 1999, Seckl & Walker 2001, Tomlinson et al .2 004, Draper & Stewart 2005 ).”
BackgroundInfluentialLiu, Y., Sun, W.-L., Sun, Y., Hu, G., & Ding, G. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00316.x · Cited by 14
Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice
Du, H., Liu, L., Wang, Y., Nakagawa, Y., Lyzlov, A., Lutfy, K., Friedman, T. C., Peng, X., & Liu, Y. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0223 · Cited by 15
Fujisawa, Y., Nakagawa, Y., Li, R.-S., Liu, Y., & Ohzeki, T. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.002 · Cited by 14
Metadata
- Authors
- Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., Malunowicz, E., White, P. C., Hewison, M., Mason, P. J., Connell, J. M., Shackleton, C. H. L., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- University of Manchester (GB)
- Manchester Royal Infirmary (GB)
- The University of Texas Southwestern Medical Center (US)
- Hammersmith Hospital (GB)
- University of Glasgow (GB)
- UCSF Benioff Children's Hospital (US)
- Corresponding author
- Stewart, Paul M
- ORCID
- Venue
- Nature Genetics
- Published
- 2003-07-13
- Volume
- 34
- Issue
- 4
- Pages
- 434-439
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2104167472
- Semantic Scholar
- cfd40673c0802069d07c6edccb428ba58392c928
- Cited by
- 285
- References
- 33
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 5 · 2014: 12 · 2013: 14 · 2012: 22
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- University Hospitals Birmingham NHS Foundation Trust
- University of Birmingham
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, hexose-6-phosphate dehydrogenase, intronic variants, NADPH regeneration, endoplasmic reticulum, glucocorticoid metabolism, ACTH, hyperandrogenism, polycystic ovary syndrome, digenic inheritance, gene transcription
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carbohydrate Dehydrogenases, Cell Line, Cortisone Reductase, Endoplasmic Reticulum, Exons, Female, Humans, Hydroxysteroid Dehydrogenases, Male, Molecular Sequence Data, Mutation, NADP, Oxidation-Reduction, Phenotype, Polycystic Ovary Syndrome, RNA, Messenger, Transfection, Case-Control Studies, Sequence Homology, Amino Acid, DNA, Complementary, 11-beta-Hydroxysteroid Dehydrogenase Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.